Matches in Wikidata for { <http://www.wikidata.org/entity/Q73645071> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q73645071 description "artículu científicu espublizáu en marzu de 2000" @default.
- Q73645071 description "im März 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73645071 description "scientific article published on 01 March 2000" @default.
- Q73645071 description "wetenschappelijk artikel" @default.
- Q73645071 description "wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch" @default.
- Q73645071 description "наукова стаття, опублікована в березні 2000" @default.
- Q73645071 name "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 name "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 type Item @default.
- Q73645071 label "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 label "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 prefLabel "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 prefLabel "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 P1433 Q73645071-C82A490B-2E48-4B4A-BC8F-DFE97E4E8041 @default.
- Q73645071 P1476 Q73645071-DA361EC4-0132-47C6-8863-2719FB47486F @default.
- Q73645071 P2093 Q73645071-1C92FE54-49F1-4BDE-B177-47A7E4E74A19 @default.
- Q73645071 P2093 Q73645071-46C0035B-2F8D-49D3-AA42-CC7E8EFC8255 @default.
- Q73645071 P2093 Q73645071-7D9230F6-1FE9-4A9B-A171-CF6B65822E60 @default.
- Q73645071 P2093 Q73645071-B0BC8A91-A7FD-4485-8E18-E24D826BF08C @default.
- Q73645071 P2093 Q73645071-DDB48F15-D5CE-473F-82CC-256BA99EBDE4 @default.
- Q73645071 P2093 Q73645071-E0050029-024F-47B5-A1B9-2E08A2341558 @default.
- Q73645071 P2093 Q73645071-EB40F697-6465-48C2-84CF-49192C4E9D95 @default.
- Q73645071 P2093 Q73645071-F3365AE3-1A27-444D-8619-19993035E6F4 @default.
- Q73645071 P2093 Q73645071-FDE5959E-DC23-40E6-8210-F5F349CC2A77 @default.
- Q73645071 P304 Q73645071-872A2637-317C-4DDE-8619-AFBF715F8C44 @default.
- Q73645071 P31 Q73645071-F638EBDD-3662-4006-8FAB-4B83ABB5EBE4 @default.
- Q73645071 P356 Q73645071-31E13385-0294-455B-9B8B-F340B83A8A56 @default.
- Q73645071 P407 Q73645071-5824EFAD-8BE6-4F3D-AD8F-4A0775E6AC0F @default.
- Q73645071 P433 Q73645071-941FCF6D-C6CA-42CF-B22E-482A85AC1102 @default.
- Q73645071 P478 Q73645071-311753CD-F1E6-4EED-BFFD-1293EECB1B61 @default.
- Q73645071 P577 Q73645071-DF8820DC-F12D-4F41-834B-67DDE046579A @default.
- Q73645071 P698 Q73645071-B84A3AA7-D9C7-4CAD-9C6D-7DB2FBBEAA8F @default.
- Q73645071 P921 Q73645071-67F8CB06-A0EA-48A3-9AD6-6577C44D307A @default.
- Q73645071 P921 Q73645071-711F9656-F2D8-4465-B869-8471CE7D58B4 @default.
- Q73645071 P921 Q73645071-CFF660C0-8F6C-48A7-A493-B968ECEE5A28 @default.
- Q73645071 P356 (SICI)1097-0215(20000320)89:2%3C111::AID-IJC2%3E3.0.CO;2-W @default.
- Q73645071 P698 10754487 @default.
- Q73645071 P1433 Q332492 @default.
- Q73645071 P1476 "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" @default.
- Q73645071 P2093 "C K Osborne" @default.
- Q73645071 P2093 "D C Allred" @default.
- Q73645071 P2093 "G M Clark" @default.
- Q73645071 P2093 "J Hill" @default.
- Q73645071 P2093 "P Ravdin" @default.
- Q73645071 P2093 "R M Elledge" @default.
- Q73645071 P2093 "R Pugh" @default.
- Q73645071 P2093 "S Green" @default.
- Q73645071 P2093 "S Martino" @default.
- Q73645071 P304 "111-117" @default.
- Q73645071 P31 Q13442814 @default.
- Q73645071 P356 "10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W" @default.
- Q73645071 P407 Q1860 @default.
- Q73645071 P433 "2" @default.
- Q73645071 P478 "89" @default.
- Q73645071 P577 "2000-03-01T00:00:00Z" @default.
- Q73645071 P698 "10754487" @default.
- Q73645071 P921 Q12859063 @default.
- Q73645071 P921 Q277954 @default.
- Q73645071 P921 Q412178 @default.